Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales
Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales.
Natco Pharma Q2 net profit jumps 83% to Rs 676 crore
Natco Pharma on November 12 said its consolidated net profit jumped 83 percent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales. The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal.
Natco Pharma Q2 net surges 83% to ₹677 crore on robust growth in formulation exports
Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 crore a year earlier, on the back of a robust growth in formulations exports.
Natco Pharma’s Q2 net up 83 per cent at ₹676 crore
Natco Pharma reports 83% increase in net profit, 35% growth in revenue, declares second interim dividend for FY2024-25.
Natco Pharma Q2 Profit Surges 83%, Declares Interim Dividend
Natco Pharma’s board declared a second interim dividend of ₹1.50 per equity share, with a face value of ₹2, for FY 2024-25.
Natco Pharma gains as Q2 PAT jumps 84% YoY to Rs 677 cr
Natco Pharma rose 1.00% to Rs 1,409.70 after the company's consolidated net profit surged 83.55% to Rs 677.30 crore in Q2 FY25 as against Rs 369 crore reported in Q2 FY24.
Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2
Natco Pharma has announced an 83 percent on-year increase in its consolidated net profit for the September 2024 quarter, which rose to Rs 676 crore, driven by strong sales performance. In
Mint1d
Natco Pharma Q2 Results Live: Profit Rises by 83.55% YoY
Natco Pharma Q2 Results Live : Natco Pharma announced its Q2 results on November 12, 2024, revealing a significant growth ...
Yahoo Finance22h
Natco Pharma Ltd (BOM:524816) Q2 FY25 Earnings Call Highlights: Robust Revenue and Profit ...
Dividend: Second interim dividend of INR1.5 per equity share for FY24-25. Natco Pharma Ltd (BOM:524816) reported a 35.3% increase in consolidated total revenue for Q2 FY25 compared to the same ...
Pharmabiz3h
Indian pharma opts for ELNs to streamline research, improve compliance and accelerate innovation
Indian pharma opts for ELNs to streamline research, improve compliance and accelerate innovation: Nandita Vijayasimha, Bengaluru Friday, November 15, 2024, 08:00 Hrs [IST] Indian ...
Daily9d
Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit
Telangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, ...
Stock market update: Nifty Pharma index 1.36% in a weak market
NEW DELHI: The Nifty Pharma index traded around 11:25AM(IST)on Wednesday in a weak market. Natco Pharma Ltd.(up 1.22 per ...